Move faster, be smarter with AI
Artificial intelligence is key for making fast, accurate decisions about drug development.
THE CHALLENGE
The hunt for new cures has been disrupted
Making fast, accurate decisions about which indications to pursue or drugs to develop is essential to pipeline success. With today’s dynamic, complex, and data-saturated environment, traditional human teams struggle to rapidly incorporate all relevant information in risk assessments and decision making.
Disruptive Innovations
Innovations in gene therapy, delivery mechanisms, and elsewhere affect drug development success.
Expiring Patents
Expiring patents of top-selling drugs present risks and opportunities for both small and large biopharmas.
Exploding Data
Unstructured data needing analysis, refinement, and processing is exploding in volume, variety, and velocity.
Evolving Regulation
Domestic and international regulations are constantly evolving in response to new discoveries.
THE SOLUTION
Leap ahead with AI-powered pipeline analysis
Powered by artificial intelligence (AI) and industry-specific large language models (LLMs), pipeline analysis platforms give experts and non-experts alike a way to unlock insights from huge amounts of data. With AI, make sophisticated pharmaceutical decisions quickly, including identifying new development opportunities, assessing the risks and likelihood of a drug’s success, and prioritizing capital allocation to the right programs.
AI helps you:
- Analyze massive volumes of data
- Assess highly complex assets and risks
- Evaluate within compressed timeframes
- Eliminate human bias, data inconsistencies, and obfuscation
Results with AI
- Analysis and results 10x faster
- Comprehensive insights across disciplines
- AI-generated insights backed by experts
- Customized reports, attributes, and scoring that matter to your decision
Uncover new possibilities with VibeOne
Learn how VibeOne can help you discover your next indication or identify high potential development opportunities in your portfolio.
